Gray Emma L, McKenzie David K, Eckert Danny J
Prince of Wales Hospital, Sydney, New South Wales, Australia.
Neuroscience Research Australia (NeuRA) and the University of New South Wales, Sydney, Australia.
J Clin Sleep Med. 2017 Jan 15;13(1):81-88. doi: 10.5664/jcsm.6394.
To determine the proportion and physiological characteristics of nonobese patients with obstructive sleep apnea (OSA) and their response to prescribed therapy.
Data from 163 consecutive in-laboratory diagnostic sleep studies for participants referred to an academic teaching-hospital sleep clinic for suspected OSA were assessed. Sleep and anthropometric parameters at baseline and follow-up (up to 22 mo) were examined and compared between obese and nonobese patients with a diagnosis of OSA (apnea-hypopnea index > 5 events/h sleep). A key nonanatomical contributor to OSA pathogenesis, the respiratory arousal threshold, was compared between groups.
Twenty-five percent of the participants with a diagnosis of OSA had a body mass index (BMI) within the normal range (BMI < 25 kg/m) and 54% had a BMI < 30 kg/m (nonobese). Of the patients prescribed continuous positive airway pressure (CPAP), more nonobese patients reported not using their CPAP machine at all at follow-up (36% vs. 13%, p = 0.03). Objective CPAP compliance was also lower in the nonobese patients with OSA (5.1 ± 0.4 vs. 6.4 ± 0.4 h/night, p < 0.03). A higher proportion of the nonobese patients had a low respiratory arousal threshold compared to obese OSA patients (86% vs. 60%, p < 0.001).
A substantial proportion of patients with OSA are not obese. These patients are challenging to treat with existing therapies as they are less adherent and compliant with CPAP therapy. Nonanatomical contributors to OSA, such a low threshold for arousal, are likely to be particularly important in OSA pathogenesis in nonobese patients with OSA. These findings have important implications for the pathogenesis of OSA in nonobese patients and potential therapeutic targets for this group of patients.
确定非肥胖型阻塞性睡眠呼吸暂停(OSA)患者的比例、生理特征及其对规定治疗的反应。
对163名因疑似OSA而转诊至一所学术教学医院睡眠诊所的参与者进行的连续实验室诊断睡眠研究数据进行评估。对诊断为OSA(呼吸暂停低通气指数>5次/小时睡眠)的肥胖和非肥胖患者在基线和随访(最长22个月)时的睡眠和人体测量参数进行检查和比较。比较了两组之间OSA发病机制的一个关键非解剖学因素,即呼吸觉醒阈值。
诊断为OSA的参与者中,25%的人体质量指数(BMI)在正常范围内(BMI<25kg/m²),54%的BMI<30kg/m²(非肥胖)。在接受持续气道正压通气(CPAP)治疗的患者中,更多非肥胖患者在随访时报告根本未使用CPAP机器(36%对13%,p=0.03)。OSA非肥胖患者的客观CPAP依从性也较低(5.1±0.4对6.4±0.4小时/晚,p<0.03)。与肥胖OSA患者相比,更高比例的非肥胖患者呼吸觉醒阈值较低(86%对60%,p<0.001)。
相当一部分OSA患者并不肥胖。这些患者对现有治疗方法具有挑战性,因为他们对CPAP治疗的依从性和顺应性较差。OSA的非解剖学因素,如低觉醒阈值,在非肥胖OSA患者的OSA发病机制中可能尤为重要。这些发现对非肥胖患者OSA的发病机制和该组患者的潜在治疗靶点具有重要意义。